NYSE · RTO

Rentokil Initial financials

$20.05−2.20%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
Revenue$6.91B$6.62B$6.38B$4.49B
Gross profit$6.91B$6.62B$6.38B$4.49B
Gross margin100.0%100.0%100.0%100.0%
Operating income$584.0M$644.0M$727.0M$383.5M
Net income$470.0M$392.0M$474.0M$280.7M
Net margin6.8%5.9%7.4%6.2%
Diluted EPS$0.19$0.16$0.19$0.14
EBITDA$1.06B$1.21B$1.22B$761.0M
Operating cash flow$972.0M$868.0M$916.0M$725.9M
Free cash flow$764.0M$649.0M$709.0M$540.8M
Diluted shares2,535.0M2,528.0M2,527.0M2,014.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31
Cash & equivalents$2.32B$1.16B$1.99B$2.63B
Short-term investments$2.0M$1.0M$1.0M$1.2M
Total debt$5.61B$4.67B$5.55B$6.06B
Total assets$14.43B$13.21B$14.17B$14.45B
Total liabilities$8.94B$7.92B$8.96B$9.49B
Shareholders' equity$5.49B$5.29B$5.21B$4.96B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology